Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error screen, while its footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:18:15.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:03:42.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the previous study record content, indicating the page is blocked from access. The header/footer remain visible while the main content is replaced by an access-denied message.
    Difference
    22%
    Check dated 2026-09-19T18:07:44.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page's documentation metadata.
    Difference
    0.0%
    Check dated 2026-08-29T20:14:32.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    The site's underlying version was updated from v3.6.4 to v3.6.5, representing a small patch that does not change the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-08T20:03:04.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a new build deployment. This appears to be an internal update with no described user-facing content changes.
    Difference
    0.0%
    Check dated 2026-07-25T11:42:08.000Z thumbnail image

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.